NYSE: TFX

Teleflex (TFX) Stock Analysis & Forecast

Nov 13 close

$155.10+1.95 (+1.3%)

Gekko Brief

AI summaryNov 9 close

Teleflex moved higher this week after third-quarter results showed a raised 2026 adjusted earnings outlook and a return to growth in the Interventional business, though the company noted a planned divestiture could close later than expected. Third-quarter revenue came in essentially flat year over year at $567.78 million, while net income turned positive to $927.43 million on a $1.0 billion pretax gain from the OEM business sale, pushing diluted EPS to $22.28. Adjusted EPS rose 39.2% year over year to $2.63 on 3% pro forma adjusted constant currency revenue growth and a 25% adjusted operating margin, beating consensus, though at least one report flagged scrutiny over guidance quality given the recent rally. The company also declared a quarterly dividend of $0.34 per share, payable 31 December to shareholders of record 16 November.

The stock closed at $154.73, up 2.6%, sitting above both its 50-day ($132.43) and 200-day ($126.50) moving averages, with the 50-day above the 200-day, and trading near its 52-week high of $156.67. The GekkoIndex reads 34.9, placing it in the Distribution zone, down 8.2 over the past five readings. Price sits 18.8% above Gekko Fair Value of $130.21.

The next earnings date falls on 25 February 2027, 107 days out, beyond a typical 20-trading-day hold. No insider, Congress or unusual options activity appears in their respective windows, though one billionaire holder is recorded. Seasonality over the next 20 trading days has averaged +4.2% across 5 years, rising in 3 of them. Analyst coverage from 10 firms shows 6 buy and 4 hold ratings, with a consensus target of $154, implying consensus downside of -0.5% from current levels.

Written by AI from the Nov 9, 2026 close and checked automatically against the figures on this page.

Teleflex price vs fair value

$155.10$129.57Nov ’25May ’26Nov ’26
Close $155.10200-day averageGekko Fair Value $129.57

Teleflex quick facts

Market cap
$6.15B
P/E ratio
75.4
Forward P/E
13.7
EPS, TTM
$2.03
Revenue, TTM
$2.26B
Profit margin
13.5%
Dividend yield
0.87%
Beta
0.83
Volume
836,394 avg 816,526
1-year return
+39.1%
Typical daily move
±3.1%
Typical 20-day move
±5.9%
50-day average
$133.56
200-day average
$127.51
Next earnings
Feb 25 before open
Shares outstanding
39.66M
52-week range
$100.18$156.75

Teleflex swing-trade checklist

Teleflex scores 3 supportive, 0 mixed and 2 headwinds across the 5 checklist items with data.

Six things swing traders check before a 20-day hold, read from the latest data.

3 supportive0 mixed2 headwinds

  • Trendsupportive

    Above 50 and 200-day

    Close $155.10 is above the 50-day ($133.56) and 200-day ($127.51) averages, and the 50-day is above the 200-day.

    See the chart
  • GekkoIndexheadwind

    43.6, Distribution

    Reading 43.6 is in the Distribution zone.

    See the GekkoIndex
  • Fair valueheadwind

    19.7% above

    Price is 19.7% above Gekko Fair Value (more than 5% above).

    See fair value
  • Smart moneyno data

    No data

    No insider, Congress or unusual options activity in the window.

    See smart money
  • Earnings risksupportive

    Reports in 102 days

    Next report Feb 25, 2027, 102 days away — outside a typical 20-trading-day hold.

    See earnings
  • Seasonalitysupportive

    +8.6% on average

    From this point in the calendar, the next 20 trading days averaged +8.6% over 5 years, rising in 3 of them.

    See seasonality

A description of current data, not a recommendation. How this page works

Teleflex stock chart and price history

Teleflex closed at $155.10 on Nov 13, 2026, +39.1% over the past year, inside a 52-week range of $100.18 to $156.75.

Close50-day average200-day averageVolume
Teleflex share price, past year, with 50-day and 200-day moving averages and volume$100$120$140DecJan 2026FebMarAprMayJunJulAugSepOctNov155.10

Use the left and right arrow keys to read daily values.

Performance Breakdown

1 month
+21.0%
3 months
+16.6%
6 months
+19.6%
1 year
+39.1%
The full TFX chart adds GekkoIndex, insider, options, Congress and hedge fund markers, plus TrendCandles™.Open TFX in Gekko

Follow Teleflex through every session

Put TFX on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.

Track TFX in GekkoFree for 7 days. No credit card required.

About Teleflex

Teleflex designs and produces disposable medical devices that clinicians rely on for both diagnosis and treatment, mainly in surgical and critical care settings. It has built recognition around its Arrow-branded vascular access tools, such as catheters and systems for guiding and positioning catheter tips, as well as the UroLift System, which addresses urinary symptoms tied to enlarged prostate conditions.

The business spans multiple product areas, including vascular access, interventional cardiology and radiology, anesthesia and surgical equipment, urology, and respiratory care. Offerings under these areas include coronary and structural heart devices, tools for peripheral vascular and cardiac procedures, pain management and surgical instruments, catheterization and endourology equipment, plus devices for oxygen delivery and breathing support. Buyers of these products include hospitals, clinicians, emergency responders, military medical units, other device makers, and providers of home healthcare.

Teleflex traces its founding to 1943 and runs its operations from Wayne, Pennsylvania. Its stock trades on the NYSE under the symbol TFX.

Listed
NYSE
Sector
Health technology
Industry
Medical specialties
Website
teleflex.com

Teleflex GekkoIndex: the smart money zone

Teleflex’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 43.6, in the Distribution zone, up 8.5 points over five sessions.

010043.6Distribution

Up 8.5 points over five sessions.

Reading for Nov 13, 2026

What followed past readings in each zone

ZoneReadings5 days10 days20 days50 days
Buying55−0.2%+0.2%+1.0%−3.9%
Accumulation291+0.4%+0.2%−0.4%−3.0%
Neutral338−0.7%−1.1%−2.4%−3.8%
Distribution (current zone)16−1.8%−6.1%−5.0%−3.5%
Selling2Too few readings yet

Average TFX share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Distribution readings averaged +1.1% over 20 days. Past behaviour doesn’t guarantee future results.

Distribution zone: Institutions potentially offloading. About the five zones →

See every daily GekkoIndex reading plotted over the TFX price, zone by zone.Track TFX in Gekko

Is Teleflex stock overvalued? Gekko Fair Value

Teleflex trades 19.7% above Gekko Fair Value of $129.57, so the shares are overvalued on Gekko’s estimate.

Gekko’s own estimate of what Teleflex shares are worth, recalculated every trading day.

$129.57

Gekko Fair Value, Nov 14, 2026

19.7% Overvalued

At the end of Aug 2026 the price was 4.4% above the estimate.

Gekko Fair ValueShare price, month end
$130$155Aug 2026SepOctNov 2026

How Gekko Fair Value works →

Gekko Fair Value on every chart, with the gap to price updating daily.Open TFX in Gekko

Teleflex insider and Congress trading

No open-market insider purchases were filed for Teleflex, and no Congress trades were disclosed, in the last 90 days.

Plus buybacks, unusual options and fund positions, each dated to when it became public.

Insider buying last 90 days

No open-market insider purchases were filed for TFX in the last 90 days.

From Form 4 filings, dated to when each was filed.

Every TFX insider filing, plotted on the chart in Gekko.Open TFX in Gekko

Congress trades last 90 days

No trades in TFX were disclosed by members of Congress in the last 90 days.

From congressional disclosures, which report amounts as ranges.

Congress disclosures for TFX, plotted on the chart in Gekko.Open TFX in Gekko

Buybacks

Teleflex has been buying back its own shares.

Bought back, quarter ended Sep 30, 2026
$305.0M
As a share of market cap
4.96%

From company filings.

Hedge funds and billionaires quarter ended Sep 30

0of the funds Gekko tracks hold TFX.

0added0opened0trimmed2sold out
Which funds are on each side, name by name.Unlock in Gekko

Teleflex earnings: next date and track record

Teleflex reports on Feb 25, 2027, before the open (102 days away), and beat the EPS estimate in 7 of its last 8 reports.

7 of 8reports beat the EPS estimate
±9.5%average move across the report
3 of 8reports followed by a gain

Share-price move across each report

−10.2%Oct ’24−25.3%Feb ’25−7.8%May ’25+1.7%Jul ’25−12.3%Nov ’25+9.1%Feb ’26+8.0%May ’26−1.3%Aug ’26

Last earnings call, Aug 6, 2026 AI summary

What they said
Teleflex reported Q2 2026 pro forma adjusted constant currency revenue growth of 4.7% with adjusted operating margin of 19.6%, beating expectations on revenue, adjusted margin, and EPS. Vascular and Surgical segments performed well, while Interventional underperformed due to slower-than-expected VI acquisition integration. The company closed its OEM divestiture generating ~$1.5B in proceeds ($1.25B after-tax), part of a broader transformation involving divestitures of Acute Care, Interventional Urology, and OEM businesses.
Guidance
Full year revenue outlook was reduced to reflect tempered Interventional growth expectations, while adjusted operating margin guidance was maintained and adjusted EPS guidance was raised. Proceeds from divestitures will fund debt reduction and share repurchases.
ReportedEPSSurpriseRevenueSurpriseMove
Aug 6, 2026$1.76
est $1.28
+37.5%$570.3M
est $559.6M
+1.9%−1.3%
May 7, 2026$1.39
est $1.21
+14.9%$548.3M
est $536.9M
+2.1%+8.0%
Feb 26, 2026$1.93
est $3.73
−48.3%$569.0M
est $919.3M
−38.1%+9.1%
Nov 6, 2025$3.67
est $3.38
+8.6%$913.0M
est $915.0M
−0.2%−12.3%
Jul 31, 2025$3.73
est $3.36
+11.0%$780.9M
est $892.9M
−12.5%+1.7%
May 1, 2025$2.91
est $2.88
+1.0%$700.7M
est $766.1M
−8.5%−7.8%
Feb 27, 2025$3.89
est $3.86
+0.8%$795.4M
est $767.1M
+3.7%−25.3%
Oct 31, 2024$3.49
est $3.39
+2.9%$764.4M
est $813.3M
−6.0%−10.2%

“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.

Teleflex stock forecast and analyst price targets

Analysts’ average 12-month price target for Teleflex is $168.09, +8.4% from the last close, from 9 firms rating the stock in the last 90 days.

$168.09consensus 12-month target, +8.4% from the last close
Low $160High $175
Buy6
Hold3
Sell0

Each firm’s latest rating in the last 90 days: 9 firms.

Latest analyst actions

DateFirmRatingTargetvs price
Nov 9Truist FinancialHold, maintained$167+7.7%
Nov 6Bank of America SecuritiesBuy, maintained——
Nov 6Raymond JamesBuy, maintained$165+6.4%
Nov 6BMO CapitalBuy, maintained$169+9.0%
Nov 6Wells FargoHold, maintained$167+7.7%
−5.0%average 20-day move after past Distribution readings
+8.6%average move over the next 20 trading days in the last 5 years
±3.1%typical daily move, from the 14-day average range

Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.

Teleflex seasonality: the next 20 trading days

Over the next 20 trading days from Nov 14, Teleflex averaged +8.6% across the last 5 years, rising in 3 of them.

Next 20 trading days, by year

−6.0%2021+20.7%2022+15.6%2023−5.6%2024+18.4%2025

Average move and hit rate

WindowAverageYears higher
Next 5 trading days0.0%3 of 5
Next 10 trading days+1.4%3 of 5
Next 15 trading days+5.0%3 of 5
Next 20 trading days+8.6%3 of 5
Next 30 trading days+8.4%3 of 5

For scale, TFX’s typical 20-trading-day move in either direction is about 5.9%.

Teleflex market cap and key statistics

Teleflex’s market cap is $6.15B, with a P/E ratio of 75.4 and revenue of $2.26B over the last twelve months.

Valuation

Market cap
$6.15B
P/E ratio
75.4
Forward P/E
13.7
EPS, TTM
$2.03
Gekko Fair Value
$129.57

Trading

Volume
836,394
Avg volume, 20 days
816,526
52-week high
$156.75
52-week low
$100.18
Shares outstanding
39.66M

Financials

Revenue, TTM
$2.26B
Profit margin
13.5%
Return on equity
2.4%
Quarterly earnings growth, YoY
−17.3%

Risk and income

Beta
0.83
Typical daily move
±3.1%
Typical 20-day move
±5.9%
Dividend yield
0.87%

Teleflex peers

Teleflex’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.

StockTodayGekkoIndex zonevs Fair Value
TMOThermo Fisher Scientific−0.2%Neutral15.0% above
ABTAbbott Laboratories+0.3%Neutral10.5% below
DHRDanaher0.0%Neutral4.7% above
ISRGIntuitive Surgical0.0%Neutral17.5% above
MDTMedtronic+0.7%Neutral14.2% below
SYKStryker−2.0%Neutral0.1% below

A peer links to its own page where one exists.

In the Buying zone today

Reporting earnings this week

Popular on Gekko

More stocks in Medical specialties

Teleflex stock FAQ

What is Teleflex’s market cap?

Teleflex’s market cap is $6.15B at the Nov 13, 2026 close of $155.10, with 39.66M shares outstanding. The shares trade on a P/E ratio of 75.4.

What is the Teleflex stock forecast?

The consensus analyst 12-month price target for Teleflex is $168.09, +8.4% from the last close. Of the 9 firms that rated the stock in the last 90 days, 6 rate it a buy, 3 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.

Is Teleflex stock overvalued or undervalued?

On Gekko’s estimate Teleflex is overvalued: the Nov 13, 2026 close of $155.10 is 19.7% above Gekko Fair Value of $129.57. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.

When does Teleflex report earnings next?

Teleflex is expected to report on Feb 25, 2027, before the market opens (102 days away). Analysts expect earnings of $1.92 per share on revenue of $577.9M. Teleflex beat the earnings estimate in 7 of its last 8 reports, moving 9.5% on average across the report.

What is Teleflex’s 52-week high and low?

Teleflex’s 52-week high is $156.75 and its 52-week low is $100.18; it closed at $155.10 on Nov 13, 2026, +39.1% over the past year. Over the last five years the shares peaked at $356.72 on Apr 4, 2022.

Is Teleflex stock a buy right now?

Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 3 of the 5 items with data read as supportive (trend, earnings risk and seasonality) and 2 as headwinds (gekkoindex and fair value). The checklist is a description of current data, not a recommendation.

How this page works

During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →

See Teleflex the way Gekko members do

Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.

Join 1,475 other traders using Gekko

Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.